One dose vaccination with Mycoplasma hyopneumoniae
US6846477B2 · kind B2 · utility
57Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 19, 2002 |
| Grant date | Jan 25, 2005 |
| Priority date | — |
| Expiry date | Jun 19, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/87
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.